Apellis Pharmaceuticals, Inc. (APLS)
APLSApellis Pharmaceuticals, Inc.loading…
loading…
QTick signal
+4net
3 bull / 1 bear factors · leaningBull 5 pts·Bear 1 pts30d
loading…
Market context—Sector read · not on fileCautionBalance sheet · Grey—PCE inflation days · not on file—Knife guard · not on file
Chart pattern
—
not on file
Volume vs its own 20-session averagenot on file
52-week range$16.61 – $41.14
Below high sincenot on file
Risk / reward—
Plan stop—
Max pain—
RSI 1458.7 fires under 35 · fires near $39.81
Forensic flags2 review
Earnings multiple38.3× trailing · forward n.m., a loss is expected
P/E vs its own past10th pctile · 66.1× median
Free cash flow yield0.9% · of market value
Entry strategy · 10 triggers
0 of 6 evaluableRSI 14
●
58.7
fires under 35 · fires near $39.81
vs 50-day
●
—
not on file
Bollinger
●
—
not on file
VWAP 20
●
—
not on file
Entry level
●
—
not on file
Put wall
●
—
not on file
MACD
Context●
-0.60
below zero · rising toward the flip
RVolStatic
—
not on file
Short int.Static
12.9%
short interest below 20%
ATRStatic
—
not on file
A checklist, not odds on a return: with only 0 usable price conditions there is nothing to line up. RSI, the 50-day average and the Bollinger band move with the price you set; the 20-day average traded price, the entry level and the busiest put strike stay fixed. MACD, RVol, Short int. and ATR are context only — they never count toward the total.
Next earnings
—
not on file
Next dividend
No indicated yield
no forward dividend on file